Expertise in
12
conditions

Michael W. Beresford

21 Queen's Street, 
Leeds, ENG, GB 
Expertise in
12
conditions
21 Queen's Street, 
Leeds, ENG, GB 

Overview

Michael Beresford practices practicing medicine in Leeds, United Kingdom.

Mr. Beresford is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Juvenile Idiopathic Arthritis (JIA), Lupus Nephritis, and Glomerulonephritis.

He is actively involved in clinical research, co-authoring 172 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

21 Queen's Street, Leeds, ENG, United Kingdom
Other Locations
Institute In The Park, Eaton Road, Eaton, OH

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial
Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial
Enrollment Status: Completed
Publish Date: May 11, 2025
Intervention Type: Other, Biological
Study Drug: Adalimumab
Study Phase: Phase 4
Phase 3 Open Label Randomised Multicentre Controlled Trial of Rituxmab and Mycophenolate Mofetil Without Oral Steroids for the Treatment of Lupus Nephritis
Phase 3 Open Label Randomised Multicentre Controlled Trial of Rituxmab and Mycophenolate Mofetil Without Oral Steroids for the Treatment of Lupus Nephritis
Enrollment Status: Terminated
Publish Date: February 01, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

172 Total Publications

Effective performance of the 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for Antineutrophil-Cytoplasmic-Antibody-Associated Vasculitis in Pediatric Patients: an ARChiVe Study.
Effective performance of the 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for Antineutrophil-Cytoplasmic-Antibody-Associated Vasculitis in Pediatric Patients: an ARChiVe Study.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: September 24, 2025

Frequently Asked Questions about Michael W. Beresford

Is Michael W. Beresford a top-rated expert for Systemic Lupus Erythematosus (SLE)?

MediFind is an objective health platform that identifies experts based on real-world data. Michael W. Beresford is classified as an Elite expert for Systemic Lupus Erythematosus (SLE), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Michael W. Beresford participate in research or clinical trials?

Yes. Michael W. Beresford has published 172 articles and abstracts on conditions like Systemic Lupus Erythematosus (SLE). You can view a list of Michael W. Beresford's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Beresford's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 20 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile